Literature DB >> 2106903

Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolites.

R E Dupuis1, S N Lichtman, G M Pollack.   

Abstract

Acute toxicity in the setting of valproic acid (valproate sodium) overdose is in most cases benign and readily reversible. However, serious toxicity has been reported. We present a case of accidental acute valproic acid overdose in a 26-month-old female, in whom serious neurological, metabolic, haematological and respiratory sequelae occurred. The major toxicity observed was delayed cerebral oedema. We also present data not previously reported, which describes the pharmacokinetic disposition of valproic acid and several of its metabolites during the course of this acute overdose. A comparison of an enzyme immunoassay and gas liquid chromatographic methodologies for measuring valproic acid in this setting is also presented. It appears that the 2-EN-valproic acid metabolite plays a role in the neurological toxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106903     DOI: 10.2165/00002018-199005010-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  22 in total

1.  Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated.

Authors:  S R Howell; G A Hazelton; C D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

2.  Treatment of accidental sodium valproate overdose with an opiate antagonist.

Authors:  G S Steiman; R W Woerpel; E S Sherard
Journal:  Ann Neurol       Date:  1979-09       Impact factor: 10.422

3.  Fatal intoxication with sodium valproate.

Authors:  R Schnabel; B Rambeck; F Janssen
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

4.  [Acute poisoning by sodium valproate].

Authors:  J P Faller; M Girardel; P Sauder; J M Haegy; G Simon
Journal:  Nouv Presse Med       Date:  1981-11-07

5.  [Fatal bone marrow involvement in voluntary acute poisoning with sodium dipropylacetate].

Authors:  A Boillot; F Bourgeois; F Barale; R Lenys; P Daoudal; J L Delacour
Journal:  Nouv Presse Med       Date:  1981-05-30

6.  Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy.

Authors:  W Löscher; H Nau; H Siemes
Journal:  Epilepsia       Date:  1988 May-Jun       Impact factor: 5.864

7.  Valproic acid: metabolite concentrations in plasma and brain, anticonvulsant activity, and effects on GABA metabolism during subacute treatment in mice.

Authors:  W Löscher; H Nau
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-05

8.  Sodium valproate poisoning. A case report.

Authors:  A C van der Merwe; C F Albrecht; M S Brink; A R Coetzee
Journal:  S Afr Med J       Date:  1985-05-04

9.  Acute valproate intoxication: biochemical investigations and hemodialysis treatment.

Authors:  P B Mortensen; H E Hansen; B Pedersen; F Hartmann-Andersen; S E Husted
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1983-02

10.  Neurological sequelae after intoxication with sodium valproate.

Authors:  D Bigler
Journal:  Acta Neurol Scand       Date:  1985-09       Impact factor: 3.209

View more
  10 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  Valproate overdose: a comparative cohort study of self poisonings.

Authors:  Geoffrey K Isbister; Corrine R Balit; Ian M Whyte; Andrew Dawson
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

3.  Valproate-Induced Hyperammonemic Encephalopathy Following Accidental Ingestion in a Toddler.

Authors:  Moftah Alhagamhmad; Aisha Elarwah; Alia Alhassony; Shirin Alougly; Hamza Milad; Aziza Dehoam; Suliman Elbrgathy; Nuri Shembesh; Emhemed Mousa; Abdulhamid ElShiky
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

4.  Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma.

Authors:  Philippe Hantson; Cécile Grandin; Thierry Duprez; Marie-Cécile Nassogne; Jean-Michel Guérit
Journal:  Eur Radiol       Date:  2004-04-29       Impact factor: 5.315

5.  Role of Free Valproic Acid Levels in a Patient with Severe Hypoalbuminemia: A Case Report.

Authors:  Tanveer Brar; Sherif Hanafy Mahmoud
Journal:  Can J Hosp Pharm       Date:  2022-07-04

6.  Neurointensive care management of raised intracranial pressure caused by severe valproic acid intoxication.

Authors:  Niklas Marklund; Per Enblad; Elisabeth Ronne-Engström
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

7.  Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy.

Authors:  Syed F Imam; Omair Ul Haq Lodhi; Rizwan Zafar; Saneeya Nasim; Waseem T Malik
Journal:  Cureus       Date:  2017-08-10

8.  Case Report: A Case of Valproic Acid-Induced Hyperammonemic Encephalopathy Associated With the Initiation of Lithium: A Re-duplicable Finding.

Authors:  Anna Levy; Etienne Very; François Montastruc; Philippe Birmes; Adeline Jullien; Louis Richaud
Journal:  Front Psychiatry       Date:  2022-05-02       Impact factor: 4.157

9.  Severe Hyponatremia Due to Valproic Acid Toxicity.

Authors:  Ena Gupta; Ryan Kunjal; James D Cury
Journal:  J Clin Med Res       Date:  2015-07-24

10.  Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice.

Authors:  Tùng Nguyễn-Thanh; Dal Kim; Sik Lee; Won Kim; Sung Kwang Park; Kyung Pyo Kang
Journal:  Int J Mol Med       Date:  2017-10-27       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.